Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.

Someone asked about the "poison pill" today milestone mentioned months ago = the reason, why a buyout of PTSC wouldn't be easy.

In simple words the poison pill was created by TPL itself via the presentations at the SHM of PTSC showing the numbers of companies, which are using the MMP, their strategy to explore the MMP etc..

And it was and is created by the amount of money TPL is demanding from the infringers.

Both shows the strength and more important for the "poison pill" the financial "asset" of the MMP -  thus it defines the value of the MMP - and thus it defines 50% of the MMP's value, which MUST equal the price to be paid for PTSC in case of a buyout (corrections welcome).

Therefore I do not see this change in the CEO position as a sign of a PTSC buyout - though it might be interesting to think about the relationship TransDimensions had with ARM...

Anyway, as I said many times before: This is a manipulated game since more than two years - and I'm more convinced than ever, that the current shareprice pattern is for a reason and is not by chance or failure of PTSC.

I'm sure, we'll soon know and I hope, it's for a good, better: great reason.

GLTA 

Please login to post a reply
gcduck
City
Rank
President
Activity Points
12161
Rating
Your Rating
Date Joined
11/16/2006
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post